Zobrazeno 1 - 10
of 11
pro vyhledávání: '"B E, Reidenberg"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 40:1394-1396
The penetration of ceftibuten, an extended-spectrum oral cephalosporin, into middle ear fluid (MEF) was evaluated in pediatric patients during a course of daily oral doses of 9 mg/kg of body weight for 10 days. Plasma and MEF collected at 2, 4, 6, or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9d42181a1797f1cae9ce9d2647a5bcf
https://doi.org/10.1128/aac.40.6.1394
https://doi.org/10.1128/aac.40.6.1394
Publikováno v:
The Pediatric infectious disease journal. 14
The efficacy and safety of ceftibuten (9 mg/kg daily for 10 days) were compared with those of amoxicillin/clavulanate (Augmentin 40 mg/kg/day given every 8 hours for 10 days) in the empiric treatment of acute otitis media in children. This was a mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3896821f5d03306e225c80ad1b0a0253
https://pubmed.ncbi.nlm.nih.gov/7567310
https://pubmed.ncbi.nlm.nih.gov/7567310
Publikováno v:
The Pediatric infectious disease journal. 14
The efficacy and safety of a 10-day course of ceftibuten oral suspension (9 mg/kg once daily) were compared with those of penicillin V (25 mg/kg/day in 3 divided doses) in children 3 to 18 years old treated for symptomatic pharyngitis and scarlet fev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9ca9598d38b96d3a926f03d1fcce684
https://pubmed.ncbi.nlm.nih.gov/7567309
https://pubmed.ncbi.nlm.nih.gov/7567309
Autor:
DUNN, JAMES J.
Publikováno v:
Diagnostic Microbiology of the Immunocompromised Host; 2009, p161-181, 21p
Publikováno v:
Clinician's Dictionary of Pathogenic Microorganisms; 2004, p237-273, 37p
Publikováno v:
American Journal of Physical Anthropology; 1993, Vol. 36 Issue S16, p5-40, 36p
Publikováno v:
American Journal of Physical Anthropology; 1993, Vol. 36 Issue S16, p46-215, 170p
A multifaceted approach to the detection and characterization of infections encountered in this high-risk patient group. Serves as a reference for laboratory professionals, infectious disease physicians, oncologists, transplant specialists, and other
Informs scientists and health care professionals about all the medically relevant aspects of this rapidly evolving field.